Tharimmune (THAR) News Today $1.56 +0.03 (+1.95%) Closing price 04:00 PM EasternExtended Trading$1.57 +0.01 (+0.64%) As of 06:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Tharimmune announces board retirements ahead of annual meetingApril 26, 2025 | investing.comTharimmune Inc.: Tharimmune Strengthens Strategic Leadership with the Appointment of Vincent LoPriore to its Board of DirectorsApril 15, 2025 | finanznachrichten.deTharimmune announces preclinical data from expanded pipeline with HS1940April 9, 2025 | markets.businessinsider.comTharimmune receives Nasdaq non-compliance noticeApril 6, 2025 | investing.comTharimmune announces FDA feedback on NDA path for TH104April 1, 2025 | markets.businessinsider.comTharimmune announces FDA feedback on TH104 NDA pathApril 1, 2025 | markets.businessinsider.comTharimmune announce preclinical TH023 resultsMarch 25, 2025 | markets.businessinsider.comTharimmune appoints new CFO following resignationMarch 1, 2025 | investing.comRodman & Renshaw Initiates Coverage of Tharimmune (THAR) with Buy RecommendationDecember 7, 2024 | msn.comTharimmune presents clinical data on TH104 for chronic pruritusNovember 19, 2024 | markets.businessinsider.comWhat's Going On With Tharimmune Shares Monday?November 18, 2024 | benzinga.comTharimmune, Inc. (NASDAQ:THAR) COO Purchases $10,100.00 in StockNovember 14, 2024 | insidertrades.comTharimmune granted patent for delivery of molecularly targeted therapeuticsNovember 13, 2024 | markets.businessinsider.comTharimmune Inc.: Tharimmune Granted European Patent for Delivery of Optimized Molecularly Targeted TherapeuticsNovember 13, 2024 | finanznachrichten.deTharimmune receives regulatory feedback from EMA for TH104 programOctober 31, 2024 | markets.businessinsider.comWhat's Going On With Tharimmune Shares Wednesday?October 31, 2024 | msn.comTharimmune Presents Favorable TH104 Phase 1 Clinical Data at the American College of Gastroenterology 2024 Annual Scientific MeetingOctober 28, 2024 | markets.businessinsider.comTharimmune (NASDAQ:THAR) Stock Quotes, Forecast and News SummaryOctober 1, 2024 | benzinga.comTHAR Stock Earnings: Tharimmune Reported Results for Q2 2024August 12, 2024 | investorplace.comTharimmune, Inc.: Tharimmune to Present at 2024 BIO International ConventionMay 29, 2024 | finanznachrichten.deTharimmune to Present at 2024 BIO International ConventionMay 29, 2024 | finance.yahoo.comShort Interest in Tharimmune, Inc. (NASDAQ:THAR) Decreases By 83.2%Tharimmune, Inc. (NASDAQ:THAR - Get Free Report) was the recipient of a large decline in short interest in the month of May. As of May 15th, there was short interest totalling 20,000 shares, a decline of 83.2% from the April 30th total of 119,000 shares. Based on an average daily trading volume, of 299,400 shares, the days-to-cover ratio is presently 0.1 days. Approximately 0.2% of the company's shares are sold short.May 28, 2024 | marketbeat.comWhy Is Tharimmune (THAR) Stock Moving Today?May 24, 2024 | investorplace.comWhy Tharimmune (THAR) Shares Are MovingMay 22, 2024 | msn.comTharimmune, Inc.: Tharimmune Announces 1-for-15 Reverse Stock SplitMay 22, 2024 | finanznachrichten.deTharimmune Announces 1-for-15 Reverse Stock SplitMay 22, 2024 | finance.yahoo.comTHAR Stock Earnings: Tharimmune Reported Results for Q4 2023May 9, 2024 | investorplace.comStonegate Healthcare Partners Updates Report on Transformative Therapies for Pruritus ManagementMay 2, 2024 | finance.yahoo.comTharimmune, Inc. (THAR)April 24, 2024 | finance.yahoo.comTharimmune Inc THARApril 18, 2024 | morningstar.comTharimmune forms advisory board to guide drug developmentApril 16, 2024 | investing.comTharimmune’s buccal film liver drug demonstrates effectiveness in Phase I trialFebruary 21, 2024 | msn.comTharimmune's Oral 'Under The Cheek' Candidate At Par With FDA-Approved Injectable With Potential For Chronic Liver DiseaseFebruary 20, 2024 | msn.comTharimmune, Inc.: Tharimmune Announces Positive Results in Phase 1 Clinical Trial of TH104, its Lead Clinical Therapeutic CandidateFebruary 20, 2024 | finanznachrichten.deTharimmune Announces Positive Results in Phase 1 Clinical Trial of TH104, its Lead Clinical Therapeutic CandidateFebruary 20, 2024 | finance.yahoo.comTharimmune’s Active Common Stock Shares UpdateFebruary 9, 2024 | msn.comTharimmune Announces Dosing of First Patient in Phase 1 Clinical Trial of TH104, its Lead Candidate for Pruritus in Primary Biliary CholangitisFebruary 5, 2024 | finance.yahoo.comTharimmune, Inc.: Tharimmune Announces Initiation of Phase 1 Clinical Trial of TH104 and Provides Business UpdateJanuary 29, 2024 | finanznachrichten.deTharimmune Announces Positive Topline Data with TH104, its Lead Candidate for Moderate-to-Severe Pruritus in Chronic Liver Disease PatientsDecember 11, 2023 | finance.yahoo.comTharimmune, Inc. Announces Closing of $11 Million Public OfferingNovember 30, 2023 | finance.yahoo.comWhy Tharimmune Stock (THAR) Is Down 70% TodayNovember 30, 2023 | msn.comWhy Is Liver Disease Focused Tharimmune Stock Trading Higher Today?November 29, 2023 | msn.comTharimmune Shares Hit 52-Week Low After Public Offering PricesNovember 29, 2023 | marketwatch.comTharimmune announces pricing of $10 million public offeringNovember 29, 2023 | msn.comCrude Oil Surges 2%; Tharimmune Shares PlummetNovember 29, 2023 | markets.businessinsider.comTharimmune, Inc. Announces Pricing of $10 Million Public OfferingNovember 29, 2023 | finance.yahoo.comWhy Is Tharimmune (THAR) Stock Down 70% Today?November 28, 2023 | investorplace.comTrading was temporarily halted for "THAR" at 07:11 PM with a stated reason of "News pending."November 21, 2023 | marketbeat.comWhy Is Tharimmune (THAR) Stock Up 113% Today?November 7, 2023 | investorplace.com Get Tharimmune News Delivered to You Automatically Sign up to receive the latest news and ratings for THAR and its competitors with MarketBeat's FREE daily newsletter. Email Address THAR Media Mentions By Week THAR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. THAR News Sentiment▼0.370.72▲Average Medical News Sentiment THAR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. THAR Articles This Week▼00▲THAR Articles Average Week Get Tharimmune News Delivered to You Automatically Sign up to receive the latest news and ratings for THAR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Minerva Neurosciences News Today Relmada Therapeutics News Today Athira Pharma News Today Flora Growth News Today Portage Biotech News Today Bright Green News Today Hoth Therapeutics News Today COSCIENS Biopharma News Today Lakeshore Biopharma News Today BioXcel Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:THAR) was last updated on 5/5/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredU.S. Stock Market Now on Verge of CollapseThe last time the U.S. economy looked like this, stocks didn't move for 16 years... And many investors lost...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tharimmune, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tharimmune With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy thar Stock Free thar Stock Alerts